Daan L. Vessies

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

CfDNA-based copy-number dynamics during anti-PD1 treatment in metastatic triple negative breast cancer.

CfDNA-based copy-number dynamics during anti-PD1 treatment in metastatic triple negative breast cancer.

Journal: Cell reports. Medicine

Published: August 06, 2024

High Prevalence of Chromosomal Rearrangements and LINE Retrotranspositions Detected in Formalin-Fixed, Paraffin-Embedded Colorectal Cancer Tissue.

High Prevalence of Chromosomal Rearrangements and LINE Retrotranspositions Detected in Formalin-Fixed, Paraffin-Embedded Colorectal Cancer Tissue.

Journal: The Journal of molecular diagnostics : JMD

Published: March 23, 2024

A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.

A scenario-drafting study to explore potential future implementation pathways of circulating tumor DNA testing in oncology.

Journal: Molecular oncology

Published: July 07, 2023

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.

Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance.

Journal: Cancers

Published: February 22, 2022

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice.

A Micro-Costing Framework for Circulating Tumor DNA Testing in Dutch Clinical Practice.

Journal: The Journal of molecular diagnostics : JMD

Published: December 24, 2021

Detection and localization of early- and late-stage cancers using platelet RNA.

Detection and localization of early- and late-stage cancers using platelet RNA.

Journal: Cancer cell

Published: December 06, 2021

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patients.

Combining variant detection and fragment length analysis improves detection of minimal residual disease in postsurgery circulating tumour DNA of stage II-IIIA NSCLC patients.

Journal: Molecular oncology

Published: October 06, 2021

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non-Small-Cell Lung Cancer.

Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non-Small-Cell Lung Cancer.

Journal: JCO precision oncology

Published: November 10, 2020

An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation Detection.

An Automated Correction Algorithm (ALPACA) for ddPCR Data Using Adaptive Limit of Blank and Correction of False Positive Events Improves Specificity of Mutation Detection.

Journal: Clinical chemistry

Published: November 05, 2020

Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors.

Monitoring of EGFR mutations in circulating tumor DNA of non-small cell lung cancer patients treated with EGFR inhibitors.

Journal: Cancer chemotherapy and pharmacology

Published: May 28, 2020

Diagnostic Strategies toward Clinical Implementation of Liquid Biopsy RAS/BRAF Circulating Tumor DNA Analyses in Patients with Metastatic Colorectal Cancer.

Diagnostic Strategies toward Clinical Implementation of Liquid Biopsy RAS/BRAF Circulating Tumor DNA Analyses in Patients with Metastatic Colorectal Cancer.

Journal: The Journal of molecular diagnostics : JMD

Published: March 18, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026